BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-606@pharmaconomics
DTSTAMP:20260707T034504Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:PVLA Approval — QTORIN™ rapamycin (estimated date)
DESCRIPTION:A final FDA approval decision on QTORIN™ rapamycin for microcystic lymphatic malformations is expected ~ Jun 30\, 2027.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1583648/000119312526133332/pvla-ex99_2.htm\n\nTrack it: https://www.pharmaconomics.com/e/606
URL:https://www.pharmaconomics.com/e/606
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:PVLA catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR